To characterize the in vivo functions of HAI-2’s KD1 and KD2 in the regulation of cellular matriptase activity and prostate cancer cell motility, we constructed domain-deleted and activity-null mutants of HAI-2 (Fig. 7A). This evidence concerns the gene SPINT2 and prostate carcinoma.